Literature DB >> 10458779

Human mast cells produce matrix metalloproteinase 9.

N Kanbe1, A Tanaka, M Kanbe, A Itakura, M Kurosawa, H Matsuda.   

Abstract

Extracellular matrix-destructive enzymes, like matrix metalloproteinases (MMP), have been recognized in the process of inflammation and tissue remodeling and repair. The affected tissues often contain markedly increased numbers of mast cells. Although mast cells are capable of activating latent collagenase and proMMP, it has so far been unknown whether human mast cells themselves produce and secrete MMP9. In this study, MMP9 production by cord blood-derived cultured human mast cells and HMC-1 human mast cells was examined by reverse-transcriptase PCR, gelatin zymography and Western blot analysis using an antibody against MMP9. Cultured mast cells and HMC-1 cells treated with phorbol 12-myristate 13-acetate were shown to express MMP9 mRNA, and the cultured conditioned media from these cells showed gelatinolytic activity, identical with MMP9. Immunohistochemical examination was performed to detect MMP9 in tissue mast cells; mast cells localized in the skin, lung and synovial tissue showed strongly positive reactions for MMP9. Thus, these findings indicate that human mast cells can produce MMP9, which might contribute to extracellular matrix degradation and absorption in the process of allergic and nonallergic responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458779     DOI: 10.1002/(SICI)1521-4141(199908)29:08<2645::AID-IMMU2645>3.0.CO;2-1

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 2.  Importance of mast cells in the pathophysiology of asthma.

Authors:  Seong H Cho; Andrea J Anderson; Chad K Oh
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

3.  Role of mast cells and myofibroblasts in human peritoneal adhesion formation.

Authors:  Xiang Xu; Avraham Rivkind; Orit Pappo; Alon Pikarsky; Francesca Levi-Schaffer
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 4.  Tissue remodeling in eosinophilic esophagitis.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart J Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

5.  Immunological Aspects of Age-Related Macular Degeneration.

Authors:  Michael J Allingham; Anna Loksztejn; Scott W Cousins; Priyatham S Mettu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Changes in transcriptional output of human peripheral blood mononuclear cells following resistance exercise.

Authors:  Lara A Carlson; S W Tighe; R W Kenefick; J Dragon; N W Westcott; R J Leclair
Journal:  Eur J Appl Physiol       Date:  2011-03-25       Impact factor: 3.078

7.  MMP-9 gene variants increase the risk for non-atopic asthma in children.

Authors:  Leonardo A Pinto; Martin Depner; Norman Klopp; Thomas Illig; Christian Vogelberg; Erika von Mutius; Michael Kabesch
Journal:  Respir Res       Date:  2010-02-24

8.  Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway.

Authors:  Norika Chiba; Kenichi Shimada; Shuang Chen; Heather D Jones; Randa Alsabeh; Anatoly V Slepenkin; Ellena Peterson; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2015-03-09       Impact factor: 5.422

9.  P2 receptor-mediated signaling in mast cell biology.

Authors:  Elena Bulanova; Silvia Bulfone-Paus
Journal:  Purinergic Signal       Date:  2009-11-17       Impact factor: 3.765

10.  Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa.

Authors:  Sachiko Mori; Ruby Pawankar; Chika Ozu; Manabu Nonaka; Toshiaki Yagi; Kimihiro Okubo
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-12       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.